Allarity Therapeutics, Inc. Interest Expense
Allarity Therapeutics, Inc. (ALLR) reported Interest Expense of $102.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-14
- Allarity Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $102.00K, a 10.87% increase year-over-year.
- Allarity Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $230.00K, a 98.28% increase year-over-year.
- Allarity Therapeutics, Inc. interest expense for the quarter ending 2023-09-30 was $34.00K, a 2.86% decline year-over-year.
- Allarity Therapeutics, Inc. interest expense for the quarter ending 2023-06-30 was $142.00K, a 330.30% increase year-over-year.
- Allarity Therapeutics, Inc. interest expense for fiscal 2023 was $498.00K, a 123.32% increase from fiscal 2022.
- Allarity Therapeutics, Inc. interest expense for fiscal 2022 was $223.00K.
- Allarity Therapeutics, Inc. interest expense for fiscal 2020 was $93.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $102.00K 10-Q · filed 2024-05-14 | $332.00K derived: sum of 2 quarters · filed 2024-05-14 | $366.00K derived: sum of 3 quarters · filed 2024-05-14 | $508.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $264.00K derived: sum of 2 quarters · filed 2024-03-08 | $406.00K derived: sum of 3 quarters · filed 2024-03-08 | $498.00K 10-K · filed 2024-03-08 | |
| 2023-09-30 | $34.00K 10-Q · filed 2023-11-14 | $176.00K derived: sum of 2 quarters · filed 2023-11-14 | $268.00K 10-Q · filed 2023-11-14 | $384.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-06-30 | $142.00K 10-Q · filed 2023-08-14 | $234.00K 10-Q · filed 2023-08-14 | $350.00K derived: sum of 3 quarters · filed 2024-05-14 | $385.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-03-31 | $92.00K 10-Q · filed 2024-05-14 | $208.00K derived: sum of 2 quarters · filed 2024-05-14 | $243.00K derived: sum of 3 quarters · filed 2024-05-14 | $276.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $151.00K derived: sum of 2 quarters · filed 2024-03-08 | $184.00K derived: sum of 3 quarters · filed 2024-03-08 | $223.00K 10-K · filed 2024-03-08 | $12.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $35.00K 10-Q · filed 2023-11-14 | $68.00K derived: sum of 2 quarters · filed 2023-11-14 | $107.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $33.00K 10-Q · filed 2023-08-14 | $72.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $39.00K 10-Q · filed 2023-05-11 | ||||
| 2021-09-30 | $27.00K 10-Q · filed 2022-11-14 | $238.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $93.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |